Researcher working with precision Quillaja saponaria feedstock for vaccine R&D and advanced immunology

Native Precision for Advanced Immunology

High-purity saponin systems and molecular components derived from selectively sourced Quillaja saponaria biomass.

Source

The Native Biological Foundation

QGB’s molecular integrity is rooted exclusively in the endemic Chilean forest. We do not process generic biomass; every extraction begins with strictly pre-selected bark.

  • Selective Botanical Profiling: Only bark meeting precise molecular criteria is chosen, guaranteeing a reproducible baseline for advanced pharmaceutical purification.
  • Native Integrity: Preserves the complex molecular diversity that only a natural ecosystem can provide.
  • Regulated Sourcing: 100% compliant with CONAF-approved management plans for full legal traceability.
Precision-sourced Quillaja saponaria feedstock samples in a laboratory setting for vaccine R&D

Producto Portafolio

We group the products by their level of technical sophistication, ensuring the focus remains on your botanical DNA.

Advanced QUIL-SAP Fractions.
The QUL-SAP Family represents a specialized range of highly refined triterpenoid saponin matrices. While all three products are derived from our selectively sourced native Quillaja saponaria biomass, they are engineered with different levels of molecular precision to meet specific immunological requirements.

Isolated Molecules: The High-Purity Standard.
This category features individual saponin molecules purified to an exceptional grade (95-99%) through advanced chromatography. These components are specifically engineered for the most demanding human and veterinary clinical research, QS-21 series and QS-7 series.

Assembled Adjuvant Systems: Advanced Delivery Platforms.
This category represents the highest level of formulation technology, where purified saponins are integrated into sophisticated molecular delivery vehicles. These ready-to-use systems—including liposomes and lipid nanoparticles—are engineered to maximize immune response stability and targeted delivery for complex vaccine candidates.

Technical Access

For specifications, documentation, or sample requests:  contact@qgbiosolutions.com